Moreover, a late stage NSCLC patient had more targeted EGFR-positive exosomes in the blood than early stage patients, thus implying that the number of EGFR-positive exosomes may be correlated with the stage of lung cancer. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.